Poststroke Hip Fracture: Prevalence, Clinical Characteristics, Mineral-Bone Metabolism, Outcomes, and Gaps in Prevention

Table 1

Sociodemographic and clinical characteristics in older hip fracture patients with and without history of stroke.

Characteristics	HF poststroke (𝑛=100)	HF without history of stroke (𝑛=661)	𝑃 value
Age, years (mean ± SD)	84.1±7.72	81.9±7.96	0.120
Age, females, years (mean ± SD)	84.1±8.03	82.5±7.59	0.264
Age, males, years (mean ± SD)	83.3±4.92	80.4±8.62	0.521
Females, %	83.0	70.0	0.011
Admitted from long-term RCF, %	50.0	26.9	0.004
Cervical/trochanteric HF, 𝑛	55/45	346/315	0.698
Coronary artery disease, %	35.0	20.9	0.002
Previous myocardial infarction, %	10.0	4.6	0.024
Hypertension, %	60.0	42.1	0.001
Atrial fibrillation, %	18.0	12.5	0.092
TIA, %	16.0	6.1	0.001
Dementia, %	47.0	26.4	0.001
Diabetes mellitus, %	19.0	16.8	0.479
COPD, %	13.0	11.1	0.583
Parkinson’s disease, %	3.0	4.6	0.473
eGFR < 60 mL/min/1.73 m², %	47.0	43.4	0.650
eGFR < 30 mL/min/1.73 m², %	7.9	4.5	0.371
ASA score ≥3, %	96.9	68.2	0.001
Current Smoker, %	6.0	5.3	0.785
Ex-smoker, %	12.0	9.1	0.365
*Alcohol overuser, %	5.0	5.6	0.795
User of walking device, %	50.0	32.2	0.001

HF: hip fracture; RCF: residential care facility; TIA: transient ischaemic attack; eGFR: estimated glomerular filtration rate; ASA: American Society of Anaesthesiologists; COPD: chronic obstructive pulmonary disease. *Three or more times per week.